Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin DisordersAtsuyuki Igarashi, Kazuhiko Takehara, Kiyoko Nashiro et al.|Journal of Investigative Dermatology|1996Cited by 438
Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.Minoru Hasegawa, Kazuhiko Takehara, Shinichi Sato et al.|PubMed|1998Cited by 140
Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosisHironobu Ihn, K. Tamaki, Shinichi Sato et al.|Clinical & Experimental Immunology|2000Cited by 94
Clinical characteristics associated with antihistone antibodies in patients with localized sclerodermaShinichi Sato, Kazuhiko Takehara, Manabu Fujimoto et al.|Journal of the American Academy of Dermatology|1994Cited by 78
Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosisKanako Kikuchi, Kunihiko Tamaki, Masahide Kubo et al.|Journal of the American Academy of Dermatology|1995Cited by 75